selected publications
- Interleukin(IL)-1/IL-6-inhibitor-associated drug reaction with eosinophilia and systemic symptoms (DReSS) in systemic inflammatory illnesses. The journal of allergy and clinical immunology. In practice. 2024 Academic Article GET IT
- The interferon-rich skin environment regulates Langerhans cell ADAM17 to promote photosensitivity in lupus. eLife. 2024 Academic Article GET IT
- Efficacy and Safety of Pharmacokinetically-Driven Dosing of Mycophenolate Mofetil for the Treatment of Pediatric Proliferative Lupus Nephritis-A Double-Blind Placebo Controlled Clinical Trial (The Pediatric Lupus Nephritis Mycophenolate Mofetil Study). Journal of clinical trials. 2024 Academic Article GET IT
- The clinical relevance of different antiphospholipid antibody profiles in pediatric rheumatology patients. Pediatric rheumatology online journal. 2024 Academic Article GET IT
- Correction: Engaging patients and parents to improve mental health intervention for youth with rheumatological disease. 2024 GET IT
- Part 5: Allogeneic HSCT in refractory SJIA with lung disease; recent cases from centers in North America & Europe. Pediatric rheumatology online journal. 2024 Academic Article GET IT
- Corrigendum: Increase in pediatric recurrent fever evaluations during the first year of the COVID-19 pandemic in North America. 2023 GET IT
-
Disease Course, Treatments, and Outcomes of Children With Systemic Juvenile Idiopathic Arthritis-Associated Lung Disease.
Arthritis care & research.
2023
Academic Article
GET IT
Times cited: 2 - Increase in pediatric recurrent fever evaluations during the first year of the COVID-19 pandemic in North America. Frontiers in pediatrics. 2023 Academic Article GET IT
- Feasibility of Conducting Comparative Effectiveness Research and Validation of a Clinical Disease Activity Score for Chronic Nonbacterial Osteomyelitis. The Journal of rheumatology. 2023 Academic Article GET IT
- Juvenile dermatomyositis disease activity is associated with the expansion of blood B and T-cell memory subsets lacking follicular markers. Arthritis & rheumatology (Hoboken, N.J.). 2023 Academic Article GET IT
-
2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases.
Arthritis & rheumatology (Hoboken, N.J.).
2023
Academic Article
GET IT
Times cited: 5 -
2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases.
Arthritis care & research.
2023
Academic Article
GET IT
Times cited: 63 - Refractory systemic onset juvenile idiopathic arthritis: current challenges and future perspectives. Annals of medicine. 2022 Review GET IT
- Chilblains-Like Lesions in Pediatric Patients: A Review of Their Epidemiology, Etiology, Outcomes, and Treatment. Frontiers in pediatrics. 2022 Review GET IT
- Social determinants of health influence disease activity and functional disability in Polyarticular Juvenile Idiopathic Arthritis. Pediatric rheumatology online journal. 2022 Academic Article GET IT
-
2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for Nonpharmacologic Therapies, Medication Monitoring, Immunizations, and Imaging.
Arthritis & rheumatology (Hoboken, N.J.).
2022
Academic Article
GET IT
Times cited: 3 - 2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for Nonpharmacologic Therapies, Medication Monitoring, Immunizations, and Imaging. Arthritis care & research. 2022 Academic Article GET IT
-
2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis.
Arthritis care & research.
2022
Academic Article
GET IT
Times cited: 1 -
2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis.
Arthritis & rheumatology (Hoboken, N.J.).
2022
Academic Article
GET IT
Times cited: 4 - Multicenter study of utility and acceptability of depression and anxiety screening in adolescents and young adults with childhood-onset systemic lupus. Arthritis care & research. 2021 Academic Article GET IT
-
Update on Juvenile Spondyloarthritis.
Pediatrics in review.
2021
Academic Article
GET IT
Times cited: 1 -
Juvenile Idiopathic Arthritis Treatment Updates.
Rheumatic diseases clinics of North America.
2021
Review
GET IT
Times cited: 1 -
Community poverty level influences time to first pediatric rheumatology appointment in Polyarticular Juvenile Idiopathic Arthritis.
Pediatric rheumatology online journal.
2021
Academic Article
GET IT
Times cited: 7 - The value of the patient global health assessment in polyarticular juvenile idiopathic arthritis: a nested cohort study. Journal of patient-reported outcomes. 2021 Academic Article GET IT
- PROMIS Computer Adaptive Tests and Their Correlation With Disease Activity in Juvenile Idiopathic Arthritis. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases. 2021 Academic Article GET IT
-
Novel Majeed Syndrome-Causing LPIN2 Mutations Link Bone Inflammation to Inflammatory M2 Macrophages and Accelerated Osteoclastogenesis.
Arthritis & rheumatology (Hoboken, N.J.).
2021
Academic Article
GET IT
Times cited: 11 - Procalcitonin Differs in Children With Infection and Children With Disease Flares in Juvenile Idiopathic Arthritis. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases. 2021 Academic Article GET IT
-
Engaging patients and parents to improve mental health intervention for youth with rheumatological disease.
Pediatric rheumatology online journal.
2021
Academic Article
GET IT
Times cited: 17 -
Chronic recurrent multifocal osteomyelitis: diagnosis and treatment.
Current opinion in pediatrics.
2021
Review
GET IT
Times cited: 3 -
New Medications Are Needed for Children With Juvenile Idiopathic Arthritis.
Arthritis & rheumatology (Hoboken, N.J.).
2020
Academic Article
GET IT
Times cited: 32 -
Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases.
The Journal of clinical investigation.
2020
Academic Article
GET IT
Times cited: 159 -
Emergent high fatality lung disease in systemic juvenile arthritis.
Annals of the rheumatic diseases.
2019
Academic Article
GET IT
Times cited: 149 -
Physician practices for withdrawal of medications in inactive systemic juvenile arthritis, Childhood Arthritis and Rheumatology Research Alliance (CARRA) survey.
Pediatric rheumatology online journal.
2019
Academic Article
GET IT
Times cited: 11 -
Gaps in Mental Health Care for Youth With Rheumatologic Conditions: A Mixed Methods Study of Perspectives From Behavioral Health Providers.
Arthritis care & research.
2019
Academic Article
GET IT
Times cited: 10 -
Neutropenia During Tocilizumab Treatment Is Not Associated with Infection Risk in Systemic or Polyarticular-course Juvenile Idiopathic Arthritis.
The Journal of rheumatology.
2019
Academic Article
GET IT
Times cited: 4 - Challenges to Practicing Pediatric Rheumatology. Rheumatic diseases clinics of North America. 2019 Information Resource GET IT
-
Serum S100A8/A9 and S100A12 Levels in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinically Inactive Disease During Anti-Tumor Necrosis Factor Therapy and Occurrence of Disease Flare After Discontinuation of Therapy.
Arthritis & rheumatology (Hoboken, N.J.).
2019
Academic Article
GET IT
Times cited: 38 -
Urine biomarkers of chronic kidney damage and renal functional decline in childhood-onset systemic lupus erythematosus.
Pediatric nephrology (Berlin, Germany).
2018
Academic Article
GET IT
Times cited: 35 -
Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti-Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive Disease.
Arthritis & rheumatology (Hoboken, N.J.).
2018
Academic Article
GET IT
Times cited: 29 -
Pediatric Rheumatology Collaborative Study Group - over four decades of pivotal clinical drug research in pediatric rheumatology.
Pediatric rheumatology online journal.
2018
Information Resource
GET IT
Times cited: 35 -
High Levels of DEK Autoantibodies in Sera of Patients With Polyarticular Juvenile Idiopathic Arthritis and With Early Disease Flares Following Cessation of Anti-Tumor Necrosis Factor Therapy.
Arthritis & rheumatology (Hoboken, N.J.).
2018
Academic Article
GET IT
Times cited: 12 -
The new Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry: design, rationale, and characteristics of patients enrolled in the first 12 months.
Pediatric rheumatology online journal.
2017
Academic Article
GET IT
Times cited: 86 -
Pilot study comparing the Childhood Arthritis & Rheumatology Research Alliance (CARRA) systemic Juvenile Idiopathic Arthritis Consensus Treatment Plans.
Pediatric rheumatology online journal.
2017
Academic Article
GET IT
Times cited: 38 -
Race, Income, and Disease Outcomes in Juvenile Dermatomyositis.
The Journal of pediatrics.
2017
Academic Article
GET IT
Times cited: 50 - Proceedings of the 2016 Childhood Arthritis and Rheumatology Research Alliance (CARRA) Scientific Meeting : Toronto, Canada. 14-17 April 2016. Pediatric rheumatology online journal. 2016 Academic Article GET IT
-
Development of a Novel Renal Activity Index of Lupus Nephritis in Children and Young Adults.
Arthritis care & research.
2016
Academic Article
GET IT
Times cited: 57 -
The Systemic Juvenile Idiopathic Arthritis Cohort of the Childhood Arthritis and Rheumatology Research Alliance Registry: 2010-2013.
The Journal of rheumatology.
2016
Academic Article
GET IT
Times cited: 24 -
Identifying Targets for Improving Mental Healthcare of Adolescents with Systemic Lupus Erythematosus: Perspectives from Pediatric Rheumatology Clinicians in the United States and Canada.
The Journal of rheumatology.
2016
Academic Article
GET IT
Times cited: 17 -
Familial autoimmunity in the Childhood Arthritis and Rheumatology Research Alliance registry.
Pediatric rheumatology online journal.
2016
Academic Article
GET IT
Times cited: 19 -
Validation of the Lupus Nephritis Clinical Indices in Childhood-Onset Systemic Lupus Erythematosus.
Arthritis care & research.
2016
Academic Article
GET IT
Times cited: 30 -
Ethnic variation of TET2 SNP rs2454206 and association with clinical outcome in childhood AML: a report from the Children's Oncology Group.
Leukemia.
2015
Letter
GET IT
Times cited: 16 -
Novel method to collect medication adverse events in juvenile arthritis: results from the childhood arthritis and rheumatology research alliance enhanced drug safety surveillance project.
Arthritis care & research.
2015
Academic Article
GET IT
Times cited: 6 -
Effects of obesity on health-related quality of life in juvenile-onset systemic lupus erythematosus.
Lupus.
2014
Academic Article
GET IT
Times cited: 20 -
Adding canakinumab to the Childhood Arthritis and Rheumatology Research Alliance consensus treatment plans for systemic juvenile idiopathic arthritis: Comment on the article by DeWitt et al.
Arthritis care & research.
2014
Letter
GET IT
Times cited: 21 -
Nfkb1 is a haploinsufficient DNA damage-specific tumor suppressor.
Oncogene.
2014
Academic Article
GET IT
Times cited: 21 -
Safety of celecoxib and nonselective nonsteroidal anti-inflammatory drugs in juvenile idiopathic arthritis: results of the Phase 4 registry.
Pediatric rheumatology online journal.
2014
Academic Article
GET IT
Times cited: 31 -
A survey of steroid-related osteoporosis diagnosis, prevention and treatment practices of pediatric rheumatologists in North America.
Pediatric rheumatology online journal.
2014
Academic Article
GET IT
Times cited: 22 -
Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial.
Annals of the rheumatic diseases.
2014
Academic Article
GET IT
Times cited: 252 -
Long-term safety and efficacy of rilonacept in patients with systemic juvenile idiopathic arthritis.
Arthritis and rheumatism.
2013
Academic Article
GET IT
Times cited: 77 -
Safety and immunogenicity of the quadrivalent HPV vaccine in female Systemic Lupus Erythematosus patients aged 12 to 26 years.
Pediatric rheumatology online journal.
2013
Academic Article
GET IT
Times cited: 77 -
Pulmonary hypertension and other potentially fatal pulmonary complications in systemic juvenile idiopathic arthritis.
Arthritis care & research.
2013
Academic Article
GET IT
Times cited: 137 -
Validation of the systemic lupus erythematosus responder index for use in juvenile-onset systemic lupus erythematosus.
Annals of the rheumatic diseases.
2013
Academic Article
GET IT
Times cited: 14 -
Inactive disease and remission in childhood-onset systemic lupus erythematosus.
Arthritis care & research.
2012
Academic Article
GET IT
Times cited: 29 -
The clinical spectrum of juvenile idiopathic arthritis in a large urban population.
Current rheumatology reports.
2012
Information Resource
GET IT
Times cited: 2 -
Anti-tumor necrosis factor therapy and cancer risk in patients with autoimmune disorders.
Arthritis care & research.
2010
Information Resource
GET IT
Times cited: 16 -
Minimal clinically important differences of disease activity indices in childhood-onset systemic lupus erythematosus.
Arthritis care & research.
2010
Academic Article
GET IT
Times cited: 29 -
Toward the development of criteria for global flares in juvenile systemic lupus erythematosus.
Arthritis care & research.
2010
Academic Article
GET IT
Times cited: 20 -
Prospective validation of the provisional criteria for the evaluation of response to therapy in childhood-onset systemic lupus erythematosus.
Arthritis care & research.
2010
Academic Article
GET IT
Times cited: 16 -
Neutrophil gelatinase-associated lipocalin is a predictor of the course of global and renal childhood-onset systemic lupus erythematosus disease activity.
Arthritis and rheumatism.
2009
Academic Article
GET IT
Times cited: 122 -
Health-related quality of life and its relationship to patient disease course in childhood-onset systemic lupus erythematosus.
The Journal of rheumatology.
2009
Academic Article
GET IT
Times cited: 40 -
Initial validation of a novel protein biomarker panel for active pediatric lupus nephritis.
Pediatric research.
2009
Academic Article
GET IT
Times cited: 105 -
Lack of association of the TP53 Arg72Pro SNP and the MDM2 SNP309 with systemic lupus erythematosus in Caucasian, African American, and Asian children and adults.
Lupus.
2009
Academic Article
GET IT
Times cited: 16 -
Do children with lupus have fewer male siblings?.
Lupus.
2008
Academic Article
GET IT
Times cited: 6 -
Neutrophil gelatinase-associated lipocalin as a biomarker of disease activity in pediatric lupus nephritis.
Pediatric nephrology (Berlin, Germany).
2008
Academic Article
GET IT
Times cited: 106 -
Multicenter validation of a new quality of life measure in pediatric lupus.
Arthritis and rheumatism.
2007
Academic Article
GET IT
Times cited: 37 -
Quality of life in children with systemic lupus erythematosus: a review.
Lupus.
2007
Information Resource
GET IT
Times cited: 16 -
Quality of life in children with systemic lupus erythematosus.
Current rheumatology reports.
2005
Information Resource
GET IT
Times cited: 11 -
Relationship of quality of life and physical function measures with disease activity in children with systemic lupus erythematosus.
Lupus.
2005
Academic Article
GET IT
Times cited: 32 -
Thalidomide for severe systemic onset juvenile rheumatoid arthritis: A multicenter study.
The Journal of pediatrics.
2004
Academic Article
GET IT
Times cited: 79 -
The genetics of familial lymphomas.
Current oncology reports.
2004
Information Resource
GET IT
Times cited: 9 -
Adverse effects of estrogen therapy in a subset of women with ITP.
Journal of thrombosis and haemostasis : JTH.
2004
Letter
GET IT
Times cited: 8 -
Combined intravenous methotrexate and cyclophosphamide for refractory childhood lupus nephritis.
Annals of the rheumatic diseases.
2004
Academic Article
GET IT
Times cited: 34 -
MDM2 and prognosis.
Molecular cancer research : MCR.
2004
Review
GET IT
Times cited: 187 -
Quality of life in paediatric lupus.
Lupus.
2004
Academic Article
GET IT
Times cited: 30 -
Differential recruitment of caspase 8 to cFlip confers sensitivity or resistance to Fas-mediated apoptosis in a subset of familial lymphoma patients.
Leukemia research.
2003
Academic Article
GET IT
Times cited: 15 -
Lyme arthritis presenting as acute septic arthritis in children.
Journal of pediatric orthopedics.
2003
Academic Article
GET IT
Times cited: 47 -
Pediatric AML: past, present, and future.
Cancer investigation.
2002
Editorial Article
GET IT
Times cited: 2 -
Benign outcome of RSV infection in children with cancer.
Medical and pediatric oncology.
2001
Academic Article
GET IT
Times cited: 14 -
Neonatal lupus erythematosus in triplets.
The Journal of rheumatology.
2000
Academic Article
GET IT
Times cited: 17 -
Advances in the medical treatment of juvenile rheumatoid arthritis.
Current opinion in pediatrics.
2000
Information Resource
GET IT
Times cited: 19 -
Intermittent intravenous cyclophosphamide arrests progression of the renal chronicity index in childhood systemic lupus erythematosus.
The Journal of pediatrics.
2000
Academic Article
GET IT
Times cited: 104 -
Molecular cloning of a gene required for DNA replication in Ustilago maydis.
Molecular & general genetics : MGG.
1997
Academic Article
GET IT
Times cited: 9 -
The REC1 gene of Ustilago maydis, which encodes a 3'-->5' exonuclease, couples DNA repair and completion of DNA synthesis to a mitotic checkpoint.
Genetics.
1996
Academic Article
GET IT
Times cited: 26 -
Levels of soluble Fas/APO-1/CD95 in systemic lupus erythematosus and juvenile rheumatoid arthritis.
Arthritis and rheumatism.
1995
Academic Article
GET IT
Times cited: 74 -
Expression and function of the murine CD95/FasR/APO-1 receptor in relation to B cell ontogeny.
European journal of immunology.
1995
Academic Article
GET IT
Times cited: 51 -
Mutation avoidance and DNA repair proficiency in Ustilago maydis are differentially lost with progressive truncation of the REC1 gene product.
Molecular and cellular biology.
1995
Academic Article
GET IT
Times cited: 26 -
The REC1 gene of Ustilago maydis involved in the cellular response to DNA damage encodes an exonuclease.
The Journal of biological chemistry.
1994
Academic Article
GET IT
Times cited: 53